Skin metabolomic profile in persistent inflammation of multifactorial origin
DOI:
https://doi.org/10.70577/jpy09g33Keywords:
skin metabolomics, persistent inflammation, epidermal barrier, dysbiosis, immunometabolism, dermatologyAbstract
The study examines persistent cutaneous inflammation of multifactorial origin, characterized by the interaction between epidermal barrier dysfunction, metabolomic alterations, microbial dysbiosis, and sustained immune activation. The objective was to analyze the skin metabolomic profile and its relationship with biophysical, immunological, and microbiological variables. A quantitative approach with a non-experimental, descriptive-explanatory design was applied, based on the review of reports from international organizations and scientific literature (2021–2023), using Pearson correlation, multiple linear regression, Cronbach’s alpha, and Shapiro–Wilk test. The results revealed a differential metabolomic signature among healthy, non-lesional, and lesional skin, highlighting alterations in lipids and amino acids; a significant inverse relationship was identified between transepidermal water loss and skin hydration, as well as a direct association between cutaneous dysbiosis, predominance of Staphylococcus aureus, and clinical severity; additionally, activation of the NAD+/NAMPT/PARP1 axis was identified as a central mechanism in persistent inflammation, along with the capacity of targeted therapies to restore epidermal functionality. It is established that the skin metabolomic profile constitutes an integrative axis for understanding persistent inflammation and guiding precision medicine strategies in dermatology.
Downloads
References
Amat-Samaranch, V., & Silvestre Salvador, J. F. (2023). Haptens, proteins, and atopic dermatitis. Actas Dermo-Sifiliográficas, 114(4), T308–T317. https://doi.org/10.1016/j.ad.2023.02.011
Arroyo, A. B., Bernal-Carrión, M., Cantón-Sandoval, J., Cabas, I., Corbalán-Vélez, R., Martínez-Menchón, T., Ferri, B., Cayuela, M. L., García-Moreno, D., & Mulero, V. (2023). NAMPT and PARylation are involved in the pathogenesis of atopic dermatitis. International Journal of Molecular Sciences, 24(9), 7992. https://doi.org/10.3390/ijms24097992
Becerra-Becerra, Y., Gómez-Moyano, E., & Martínez-Pérez, M. (2023). Avances en el estudio metabolómico de enfermedades inflamatorias cutáneas. Revista Latinoamericana de Dermatología, 41(2), 85–97. https://doi.org/10.1016/j.rld.2023.02.005
Carmona-Cruz, S., Orozco-Covarrubias, L., & Sáez-de-Ocariz, M. (2022). The human skin microbiome in selected cutaneous diseases. Frontiers in Cellular and Infection Microbiology, 12, 834135. https://doi.org/10.3389/fcimb.2022.834135
Carrascosa, J. M., Puig, L., Belinchón Romero, I., Salgado-Boquete, L., Del Alcázar, E., Andrés Lencina, J. J., Moreno, D., & de la Cueva, P. (2022). Practical update of the recommendations published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPS) on the treatment of psoriasis with biologic therapy. Part 1. Concepts and general management of psoriasis with biologic therapy. Actas Dermo-Sifiliográficas, 113(3), 261–277. https://doi.org/10.1016/j.ad.2021.10.003
Castillo-González, R., Fernández-Delgado, I., & Comberiati, P. (2022). Bacteriotherapy with human skin commensals in atopic dermatitis. Allergy, 77(4), 1331–1333. https://doi.org/10.1111/all.15162
Fernández-Gallego, N., Castillo-González, R., Méndez-Barbero, N., López-Sanz, C., Obeso, D., Villaseñor, A., Escribese, M. M., López-Melgar, B., Salamanca, J., Benedicto-Buendía, A., Jiménez-Borreguero, L. J., Ibañez, B., Sastre, J., Belver, M. T., Vega, F., Blanco, C., Barber, D., Sánchez-Madrid, F., de la Fuente, H., Martín, P., Esteban, V., & Jiménez-Saiz, R. (2022). The impact of type 2 immunity and allergic diseases in atherosclerosis. Allergy, 77(11), 3249–3266. https://doi.org/10.1111/all.15426
Ilves, T., Harvima, I. T., & Peltonen, S. (2021). Skin metabolomics and inflammatory skin diseases: Current perspectives. Acta Dermato-Venereologica, 101(10), adv00567. https://doi.org/10.2340/00015555-3766
Khadka, V. D., Key, F. M., Romo-González, C., Martínez-Gayosso, A., Campos-Cabrera, B. L., Gerónimo-Gallegos, A., Lynn, T. C., Durán-McKinster, C., Coria-Jiménez, R., Lieberman, T. D., & García-Romero, M. T. (2021). The skin microbiome of patients with atopic dermatitis normalizes gradually during treatment. Frontiers in Cellular and Infection Microbiology, 11, 720674. https://doi.org/10.3389/fcimb.2021.720674
Leyva-Castillo, J. M., Abdelhamid, M., Shirey, M., Sun, J., Thomas, J. M., Ikediobi, O., Trempus, C., McGurk, A., & Arbiser, J. L. (2023b). Ant venom-based ceramide therapy is effective against atopic dermatitis and psoriasis. Journal of Drugs in Dermatology, 22(10), 1001–1006. https://doi.org/10.36849/JDD.7308
Leyva-Castillo, J.-M., McGurk, A., Strakosha, M., Vega-Mendoza, D., Smith, S. E., Stafstrom, K., Elkins, M., Chou, J., Wang, Y.-H., & Geha, R. S. (2023a). IL-4 receptor alpha blockade dampens allergic inflammation and upregulates IL-17A expression to promote S. aureus clearance in antigen sensitized mouse skin. Journal of Allergy and Clinical Immunology, 152(4), 907–915. https://doi.org/10.1016/j.jaci.2023.05.025
Martínez-Morcillo, F. J., Cantón-Sandoval, J., Martínez-Menchón, T., Corbalán-Vélez, R., Mesa-Del-Castillo, P., Pérez-Oliva, A. B., García-Moreno, D., & Mulero, V. (2021a). Non-canonical roles of NAMPT and PARP in inflammation. Developmental and Comparative Immunology, 115, 103881. https://doi.org/10.1016/j.dci.2020.103881
Martínez-Morcillo, F. J., Cantón-Sandoval, J., Martínez-Navarro, F. J., Cabas, I., Martínez-Vicente, I., Armistead, J., Hatzold, J., López-Muñoz, A., Martínez-Menchón, T., Corbalán-Vélez, R., Pérez-Oliva, A. B., Mesa-Del-Castillo, P., García-Moreno, D., & Mulero, V. (2021b). NAMPT-derived NAD+ fuels PARP1 to promote skin inflammation through parthanatos cell death. PLoS Biology, 19(10), e3001455. https://doi.org/10.1371/journal.pbio.3001455
Montero-Vílchez, T., Cuenca-Barrales, C., Rodríguez-Pozo, J.-A., Díaz-Calvillo, P., Tercedor-Sánchez, J., Martínez-López, A., Molina-Leyva, A., & Arias-Santiago, S. (2022a). Epidermal barrier function and skin homeostasis in atopic dermatitis: The impact of age. Life, 12(1), 132. https://doi.org/10.3390/life12010132
Montero-Vílchez, T., Rodríguez-Pozo, J.-A., Díaz-Calvillo, P., Salazar-Nievas, M., Tercedor-Sánchez, J., Molina-Leyva, A., & Arias-Santiago, S. (2022b). Dupilumab improves skin barrier function in adults with atopic dermatitis: A prospective observational study. Journal of Clinical Medicine, 11(12), 3341. https://doi.org/10.3390/jcm11123341
Montero-Vílchez, T., Sanabria-de-la-Torre, R., Sánchez-Díaz, M., Ureña-Paniego, C., Molina-Leyva, A., & Arias-Santiago, S. (2023). The impact of dupilumab on skin barrier function: A systematic review. Journal of the European Academy of Dermatology and Venereology, 37(7), 1284–1292. https://doi.org/10.1111/jdv.19081
Montero-Vílchez, T., Segura-Fernández-Nogueras, M. V., Pérez-Rodríguez, I., Soler-Gongora, M., Martínez-López, A., Fernández-González, A., Molina-Leyva, A., & Arias-Santiago, S. (2021). Skin barrier function in psoriasis and atopic dermatitis: Transepidermal water loss and temperature as useful tools to assess disease severity. Journal of Clinical Medicine, 10(2), 359. https://doi.org/10.3390/jcm10020359
Paganelli, A., Rinaldi, F., & Giacomoni, P. (2022). Metabolomics in dermatology: Advances and perspectives. International Journal of Molecular Sciences, 23(17), 9876. https://doi.org/10.3390/ijms23179876
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Jessica Alejandra Martinez Soto (Autor/a)

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





